Skip to content

Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of stroke

Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of stroke - J-STARS Genomics

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008055
Enrollment
1000
Registered
2012-06-01
Start date
2010-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

None listed

Sponsors

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences
Lead Sponsor
signpost corporation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)The enrolled subjects in JSTARS study (2)The subjects from whom the informed consent was obtained

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Genetic markers responsible to the high risk of stroke recurrence , efficacy of HMG-CoA inhibitor, and appearance of cognitive impairment

Countries

Japan

Contacts

Public ContactTomohisa Nezu

Hiroshima University Graduate School of Biomedical Sciences Department of Clinical Neuroscience and Therapeutics

naika3@hiroshima-u.ac.jp082-257-5201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026